DSC
AGN

Duncker Streett & Co’s Allergan plc AGN Stock Holding History

Duncker Streett & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,270
Closed -$225K – 564
2020
Q1 		$225K Sell
1,270
-2,072
-62% -$390K 0.06% 222
2019
Q4 		$639K Sell
3,342
-500
-13% -$90.2K 0.13% 158
2019
Q3 		$647K Sell
3,842
-340
-8% -$55.4K 0.15% 149
2019
Q2 		$700K Sell
4,182
-2,105
-33% -$291K 0.16% 144
2019
Q1 		$920K Sell
6,287
-355
-5% -$51.5K 0.21% 119
2018
Q4 		$888K Sell
6,642
-275
-4% -$45.1K 0.24% 116
2018
Q3 		$1.32M Sell
6,917
-468
-6% -$86K 0.3% 106
2018
Q2 		$1.23M Sell
7,385
-235
-3% -$37.7K 0.31% 102
2018
Q1 		$1.28M Sell
7,620
-3,226
-30% -$541K 0.32% 101
2017
Q4 		$1.77M Sell
10,846
-2,157
-17% -$387K 0.46% 65
2017
Q3 		$2.67M Sell
13,003
-115
-0.9% -$26.7K 0.81% 33
2017
Q2 		$3.19M Buy
13,118
+230
+2% +$54K 0.99% 22
2017
Q1 		$3.08M Buy
12,888
+330
+3% +$76.8K 0.97% 25
2016
Q4 		$2.64M Sell
12,558
-862
-6% -$179K 0.88% 29
2016
Q3 		$3.09M Sell
13,420
-382
-3% -$93.3K 1.07% 18
2016
Q2 		$3.19M Buy
13,802
+2,881
+26% +$664K 1.13% 18
2016
Q1 		$2.93M Buy
10,921
+71
+0.7% +$20.3K 1.08% 22
2015
Q4 		$3.39M Sell
10,850
-484
-4% -$144K 1.27% 11
2015
Q3 		$3.08M Sell
11,334
-350
-3% -$108K 1.2% 14
2015
Q2 		$3.55M Sell
11,684
-1,380
-11% -$412K 1.24% 11
2015
Q1 		$3.89M Buy
13,064
+2,965
+29% +$845K 1.27% 12
2014
Q4 		$2.6M Buy
10,099
+40
+0.4% +$10K 0.85% 30
2014
Q3 		$2.43M Buy
10,059
+244
+2% +$54.6K 0.83% 29
2014
Q2 		$2.19M Buy
9,815
+75
+0.8% +$15.5K 0.71% 37
2014
Q1 		$2M Sell
9,740
-50
-0.5% -$9.9K 0.71% 38
2013
Q4 		$1.65M Buy
+9,790
New +$1.53M 0.59% 45
2013
Q3 		– Sell
-14,040
Closed -$1.77M – 564
2013
Q2 		$1.77M Buy
+14,040
New +$1.59M 0.68% 40

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Duncker Streett & Co's AGN Position: Q2 2020 in Review

Duncker Streett & Co sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,270 shares — an estimated $225K sold.

Duncker Streett & Co first reported a position in AGN in Q2 2013 and held it in 27 quarters. The position peaked at $3.89M in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Duncker Streett & Co reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Duncker Streett & Co sold 1,270 Allergan plc shares in Q2 2020, an estimated $225K.
  • Duncker Streett & Co first reported a position in Allergan plc in Q2 2013 and held it in 27 quarters.
  • Duncker Streett & Co's Allergan plc position peaked at $3.89M in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Duncker Streett & Co's 13F filing for Q2 2020, filed 22 Jul 2020.